Aurora Cannabis reports a net loss of 905 million euros
Canadian cannabis producer Aurora Cannabis reported a net loss of around 905 million euros (CAD 1.3 billion) for the second fiscal quarter, with net revenues of 44 million euros, down from 49 million euros in the first fiscal quarter.
The company also reported that its international revenues from the export of medical cannabis had fallen sharply, from around 3.5 million euros last quarter to around 1.39 million euros this quarter. The company attributed this drop to «a temporary interruption in sales» in Germany and Italy.
However, the company's shares were still up over 3% after the publication of the financial report.
Aurora CFO Glen Ibbott said in a statement that, despite the massive losses, the company was «confident» that its run rate would be «around C$40-45 million» (€28-32 million) by the end of the fourth fiscal quarter. Ibbott has declared that recent «transformation actions» undertaken by the company «had already had a positive impact on selling, administrative and other general expenses».
These changes included the departure of Aurora co-founder and CEO Terry Booth and the addition of two new independent directors. Executive Chairman Michael Singer was appointed interim CEO, and the company said it would implement a «business transformation plan».
In the last fiscal quarter, Aurora produced 30,691 kilograms of cannabis, compared to 41,436 in the previous quarter, a decline of 26% mainly due to previously announced changes in cultivation strategies, including a pivot to high-margin, high-dosage varieties in cannabinoids, and low yield.” The cost of producing a gram of cannabis sold was 88 cents CAD (€0.61), compared with 85 cents (€0.59) in the previous quarter.
The company expects its third-quarter results «to show modest to zero growth» compared with the second-quarter report.
«In line with Aurora's publication dated February 6, 2020, we are optimistic about the long-term potential of the global cannabis opportunity. However, due to several short-term factors, the industry's growth rate is likely to be slower than expected in the coming months.»
Medical Cannabis in Germany: THC Prices Vary by a Factor of 12
France already has 3,000 cannabis retail outlets. None of them are legal.
Morocco's exports of legal cannabis have expanded to 15 countries
Aurora Cannabis Doubles Its Production Capacity in Germany
Tilray is accelerating its operations in Europe thanks to a license in Portugal
Boston will host the 10th annual State of the Cannabis Industry Conference on October 26
A DEA report confirms that there are no fatal cannabis overdoses
A British patient is challenging the NHS's refusal to reimburse medical cannabis
October 2026 CBD Highlights: 10 Strains and Hash to Discover from 5 French Producers
CBD in France: Traceability, Retail Stores, THC and Driving… What the New Bill Proposes
-
Business2 weeks agoThe legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks agoWhich countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164
-
Cannabis in France2 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts
You must be logged in to post a comment Login